Dr Nathan Hill

MedInfomatics Ltd

Dr Hill has specialised in clinical note software development over the last 10 years.

A passion for combining biology and computer technology together became apparent during undergraduate study of a B.S.c in Biochemistry followed by an M.S.c in Computing at Cardiff University.

Dr Hill’s academic career culminated in a PhD Studentship at the Tenovus Centre for Cancer Research at the Welsh School of Pharmacy at Cardiff University.

More recently, Dr Hill enjoys a senior leadership role at both OnICS Ltd, which has a US focus, and, more recently MedInfomatics Ltd through which the flagship iNOTZ clinical documentation product will be launched in the UK market in 2019.

Dr Hill is very proud to have been able to live in Cardiff all of his life whereby both OnICS and the core research and development activities of MedInfomatics are based at the Cardiff Medicentre, near the University Hospital of Wales.

dont miss

Electronic Medical Records – have they lived up to expectations?

After two decades of electronic health records being rolled out across the globe, have they lived up to expectations versus original paper-based approaches?

As a result of the attempt to move away from paper to more ‘digital’ approaches, Dr Hill will explore how has this affected patient care, asking has it been beneficial to patients and health professionals or has it been a hindrance to their day to day work?


  • Professor Sun Myint: Speaking at the Oncology Convention

    Professor Sun Myint
    Clatterbridge Cancer Centre (Private Clinic)

    Rectal cancer- Do patients have a choice?

  • Ms Claire Barnard: Speaking at the Oncology Convention

    Ms Claire Barnard

    Surface-Guided Radiotherapy and Optimal Breast Cancer Treatment

  • Khurum Khan: Speaking at the Oncology Convention

    Khurum Khan
    Royal Marsden NHS Foundation Trust

    Biomarkers of response and/or resistance to targeted therapies in refractory mCRC

  • Stuart Dollow: Speaking at the Oncology Convention

    Stuart Dollow
    Vermilion Life Sciences Ltd

    Reengineering Medicines Development

  • Dr. Petr Kavan: Speaking at the Oncology Convention

    Dr. Petr Kavan
    McGill Young Adults Oncology Program

    Comparing Clinical Characteristics and Outcomes of Young-onset and Late-Onset Colorectal Cancer